These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25271108)

  • 1. Interplay of drug metabolizing enzymes with cellular transporters.
    Böhmdorfer M; Maier-Salamon A; Riha J; Brenner S; Höferl M; Jäger W
    Wien Med Wochenschr; 2014 Nov; 164(21-22):461-71. PubMed ID: 25271108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of Chemotherapy in Hepatocellular Carcinoma Due to Impaired and Dysregulated Primary Liver Drug Metabolizing Enzymes and Drug Transport Proteins: What to Do?
    Ul-Islam S; Ahmed MB; Shehzad A; Ul-Islam M; Lee YS
    Curr Drug Metab; 2018; 19(10):819-829. PubMed ID: 29807513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer.
    Alonso-Peña M; Espinosa-Escudero RA; Soto-Muñiz M; Sanchon-Sanchez P; Sanchez-Martin A; Marin JJ
    Pharmacogenomics; 2019 Aug; 20(13):957-970. PubMed ID: 31486734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs.
    Nies AT; Schwab M; Keppler D
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):545-68. PubMed ID: 18484914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma.
    Chen J; Jin R; Zhao J; Liu J; Ying H; Yan H; Zhou S; Liang Y; Huang D; Liang X; Yu H; Lin H; Cai X
    Cancer Lett; 2015 Oct; 367(1):1-11. PubMed ID: 26170167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes.
    Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Curr Pharm Des; 2013; 19(40):7126-40. PubMed ID: 23829373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
    Bhagyaraj E; Ahuja N; Kumar S; Tiwari D; Gupta S; Nanduri R; Gupta P
    Cell Cycle; 2019 Dec; 18(24):3589-3602. PubMed ID: 31739702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
    Joyce H; McCann A; Clynes M; Larkin A
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical ABC transporters and cancer chemotherapeutic drug disposition.
    Durmus S; Hendrikx JJ; Schinkel AH
    Adv Cancer Res; 2015; 125():1-41. PubMed ID: 25640265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma.
    Mehdizadeh A; Somi MH; Darabi M; Jabbarpour-Bonyadi M
    Mol Biol Rep; 2016 Feb; 43(2):107-16. PubMed ID: 26767647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells.
    Cetin M; Odabas G; Douglas LR; Duriez PJ; Balcik-Ercin P; Yalim-Camci I; Sayan AE; Yagci T
    Cells; 2019 Mar; 8(3):. PubMed ID: 30832318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug metabolizing enzymes and their inhibitors' role in cancer resistance.
    Pathania S; Bhatia R; Baldi A; Singh R; Rawal RK
    Biomed Pharmacother; 2018 Sep; 105():53-65. PubMed ID: 29843045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents.
    Rochat B
    Curr Cancer Drug Targets; 2009 Aug; 9(5):652-74. PubMed ID: 19686091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.
    Bai X; Chen Y; Hou X; Huang M; Jin J
    Drug Metab Rev; 2016 Nov; 48(4):541-567. PubMed ID: 27320238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting caspase - dependent apoptosis in hepatocellular carcinoma.
    Niotis A; Petrogiannopoulos L; Niotis T; Tsiambas E
    J BUON; 2020; 25(1):583. PubMed ID: 32277689
    [No Abstract]   [Full Text] [Related]  

  • 19. Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells.
    Ceballos MP; Angel A; Delprato CB; Livore VI; Ferretti AC; Lucci A; Comanzo CG; Alvarez ML; Quiroga AD; Mottino AD; Carrillo MC
    Eur J Pharmacol; 2021 Feb; 892():173736. PubMed ID: 33220273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of xenobiotic glucuronidating enzymes in drug resistance of tumour tissues and cells.
    Burchell B; Baird S; Coughtrie MW
    Princess Takamatsu Symp; 1990; 21():263-75. PubMed ID: 1966888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.